The global intrauterine devices market size reached US$ 4.15 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2027, exhibiting at a CAGR of 4.9% during 2022-2027.
Intrauterine devices (IUDs) are small T-shaped contraceptive devices which are placed in the uterus to prevent the implantation of fertilized ova. They are a form of long-acting reversible contraceptives (LARC) which help in birth control. IUDs can last for an extended period of 5 to 10 years, depending on the type. The hormones or copper in these devices change the cervical mucus lining, which prevents pregnancy. These devices have gained immense traction over the past decade due to the minimal side effects and discomfort associated with them. Moreover, they are highly cost-effective and available at efficient rates, making them more preferable over other methods of contraception.
Growing rates of unintended pregnancies and unplanned births across the globe have increased the awareness among women regarding the benefits of contraceptive devices like IUDs as a precautionary measure. In confluence with this, several governments and non-profit organizations have taken initiatives to inform the masses about family planning, the advantages of contraceptives, and the health issues caused by unexpected pregnancies, which, in turn, is providing a thrust to the market growth. For instance, The International Federation of Gynaecology and Obstetrics (FIGO) is working toward improving women’s health by addressing the high maternal mortality rates in low resource countries. It is also encouraging women to make informed decisions about effective contraceptive methods. Furthermore, manufacturers are innovating with their products and have introduced advanced variants like slimmer and reusable IUDs. For instance, the copper IUD does not alter the hormone levels in a woman’s body. Moreover, it has an extremely low risk of ectopic pregnancy. As a result, it is gaining popularity among nulliparous women and adolescents.
Request for a sample copy of this report: https://www.imarcgroup.com/intrauterine-devices-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Intrauterine Devices Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of the key players operating in the market include Actavis, Bayer, Teva Pharmaceuticals, Allergan, ANI Pharmaceuticals, Eurogine, OCON Medical, Pregna, SMB Corporation, HLL Lifecare, HRA Pharma and Besins HealthCare.
Explore full report with table of contents: https://bit.ly/3ahxlo9
Key Insights from the report
On the basis of products, the market has been bifurcated into hormonal and copper IUDs. Presently, hormonal IUDs account for the largest market share, representing the most popular product type.
Based on end-use segments, hospitals are the major end-users of intrauterine devices, holding the dominant share. Other categories include gynaecology clinics and community healthcare centers.
Region-wise, the market has been segmented into Europe, Asia Pacific, North America, Latin America, and Middle East and Africa. Among these, North America exhibits a clear dominance, accounting for the biggest market share.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St
Sheridan, WY 82801
Follow us on twitter: @imarcglobal
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.